medicalxpress.com
medicalxpress.com
rd.springer.com
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
February 13, 2025
07:30 PM - 09:00 PM PT
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
AI in Elderly Care: Balancing Safety, Efficiency, and Human Connection
AI in Elderly Care: Balancing Safety, Efficiency, and Human Connection
AI and CRISPR: A Transformational Alliance in Medicine and Beyond
AI and CRISPR: A Transformational Alliance in Medicine and Beyond
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
February 14, 2025
06:00 PM - 08:00 PM PST
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Objective Measures and Endoscopic Improvement
Objective Measures and Endoscopic Improvement
Best Practices for an Aesthetic Neurotoxin Approach
Best Practices for an Aesthetic Neurotoxin Approach
Advancing the Transabdominal Cerclage Through Robotics
Advancing the Transabdominal Cerclage Through Robotics
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Gene Therapy: Changing the Landscape of Hemophilia B Care
Gene Therapy: Changing the Landscape of Hemophilia B Care
